Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1999-7-22
pubmed:abstractText
Refractory acute cellular rejection may occur despite triple-drug immunosuppression (cyclosporine A, steroids, azathioprine/mycophenolate mofetil). The purpose of this study was to determine the efficacy of tacrolimus rescue therapy in patients maintained on cyclosporine-based immunosuppression (CBI).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1053-2498
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
448-55
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10363689-Acute Disease, pubmed-meshheading:10363689-Adult, pubmed-meshheading:10363689-Aged, pubmed-meshheading:10363689-Biopsy, pubmed-meshheading:10363689-Cyclosporine, pubmed-meshheading:10363689-Drug Therapy, Combination, pubmed-meshheading:10363689-Female, pubmed-meshheading:10363689-Follow-Up Studies, pubmed-meshheading:10363689-Glucocorticoids, pubmed-meshheading:10363689-Graft Rejection, pubmed-meshheading:10363689-Heart-Lung Transplantation, pubmed-meshheading:10363689-Humans, pubmed-meshheading:10363689-Immunosuppressive Agents, pubmed-meshheading:10363689-Incidence, pubmed-meshheading:10363689-Male, pubmed-meshheading:10363689-Middle Aged, pubmed-meshheading:10363689-Muromonab-CD3, pubmed-meshheading:10363689-Retrospective Studies, pubmed-meshheading:10363689-Severity of Illness Index, pubmed-meshheading:10363689-Tacrolimus, pubmed-meshheading:10363689-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
pubmed:affiliation
Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine, Madison, USA.
pubmed:publicationType
Journal Article, Comparative Study